Beilstein J. Org. Chem.2021,17, 2968–2975, doi:10.3762/bjoc.17.206
-anilinoquinazoline; anticancer agents; N-arylation; 4-chloroquinazoline; microwave irradiation; Introduction
N-Heterocyclic compounds are commonly present in pharmaceuticals, bioactive natural products, agrochemicals, and synthetic drugs [1][2]. Quinazoline, a benzo-fused N-heterocyclic framework (benzo-1,3-diazine
of the anticancer agent verubulin. Thus, after regioselective 4-chloroquinazoline metalation by an in situ trapping metalation strategy, reaction quenching with iodine allowed us to isolate 4-chloro-8-iodoquinazoline in 83% yield. Surprisingly, further reaction of 4-chloro-8-iodoquinazoline with 4
-bromo-4-chloro-2-phenylquinazoline (8a), which provided the respective products 15e–g in yields ranging from 92 to 96% (Scheme 4).
Finally, to illustrate the importance and scope of the methodology, we used the commercially available 4-chloroquinazoline (16) and 4-chloro-2-methylquinazoline (17), which
PDF
Graphical Abstract
Figure 1:
Some antitumor agents containing the 4-anilinoquinazoline moiety.
Beilstein J. Org. Chem.2020,16, 362–383, doi:10.3762/bjoc.16.35
quinazolinones 89. Subsequent chlorination of the quinazolinone resulted in the formation of 4-chloroquinazoline intermediates 90. The subsequent Pd-catalyzed coupling of 90 and arylboronic acid 91 gave the methoxy intermediates 92 in reasonable yields. The demethylation of the 2-(2-pyridyl)methoxy intermediate